US Stock MarketDetailed Quotes

GSK GlaxoSmithKline

Watchlist

38.740
+0.220+0.57%

Close Mar 28 16:00 ET

38.640
-0.100-0.26%

Post 20:01 ET

78.76BMarket Cap24.05P/E (TTM)

GlaxoSmithKline Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

GlaxoSmithKline Q4 2024 Earnings Date

Currency：GBPFeb 5, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	7.75B	8.12B	+366.25M
Beat Est.	-3.74%	+0.81%	+4.73%
EPS	0.40	0.20	-0.20
Miss Est.	+135.30%	+17.65%	-50.32%

Analyst Rating

Hold

Mar 6, 2025

GlaxoSmithKline Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: GBP

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 8.057B	--
--	2025/Q1	-- / 7.524B	--
Feb 5, 2025	2024/Q4	8.117B / 7.751B	--
Oct 30, 2024	2024/Q3	8.012B / 8.007B	--
Jul 31, 2024	2024/Q2	7.884B / 7.493B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 8.057B--

--2025/Q1-- / 7.524B--

Feb 5, 20252024/Q48.117B / 7.751B--

Oct 30, 20242024/Q38.012B / 8.007B--

Jul 31, 20242024/Q27.884B / 7.493B--

Unlock Free Earnings Estimates

Open Account

GlaxoSmithKline Earnings Reports

6-K: Gsk Plc 2024 Annual Report on Form 20-F

Mar 3 12:47 ET

20-F: FY2024 Annual Report

Mar 3 11:05 ET

6-K: Gsk Delivers Strong 2024 Performance with Further Improvement to Long-Term Growth Outlook

Feb 5 12:00 ET

6-K: Gsk on track to deliver 2024 outlooks with further good progress made in r&d

Oct 30, 2024 11:27 ET

Market Insights

Symbol Mini Chart % Chg

DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS

Collegium Pharmaceutical

AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS

AIPUY

0.00%

Unlock the Full List

Analysis

Analyst Rating

Updated: Mar 6, 2025

Hold

Buy
0.00%
Hold
100.00%
Sell
0.00%

Price Target

No Data